News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Roche (RHHBY) Share Discount Widens Speculation That Rival Novartis AG (NVS) Will Sell Its $14.1 Billion Stake


12/17/2013 7:45:23 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

The record discount in Roche Holding AG (RO) voting shares signals increasing speculation cross-town rival Novartis AG (NOVN) will sell its $14.1 billion stake into the market. Traders have pushed Roche’s voting shares to the lowest price versus its non-voting stock since at least 1989, a sign they are preparing for dilution should Novartis sell its 33 percent stake in the equities, said Ben Kelly, an analyst at Louis Capital Markets. The discount is an anomaly.

Help employers find you! Check out all the jobs and post your resume.

Read at Bloomberg


comments powered by Disqus
Bloomberg
Novartis AG
Roche
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES